RAC 5.15% $1.84 race oncology ltd

Ann: Race Initiates FTO Melanoma Preclinical Study, page-73

  1. 15,728 Posts.
    lightbulb Created with Sketch. 1793
    Yes Prof ZHAO is the prefect candidate to undertake our FTO preclinical study on Bisantrene as inhibitor .

    Professor Zhang and his team found they could inhibit the growth of melanoma cells, and even shrink established melanomas by restoring PIB5PA levels.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.84
Change
-0.100(5.15%)
Mkt cap ! $315.1M
Open High Low Value Volume
$1.95 $1.95 $1.84 $470.5K 250.5K

Buyers (Bids)

No. Vol. Price($)
2 39053 $1.84
 

Sellers (Offers)

Price($) Vol. No.
$1.86 3680 1
View Market Depth
Last trade - 13.40pm 15/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.